Key TakeawaysPfizer (PFE) and Astellas Pharma announced that their combination therapy XTANDI plus leuprolide significantly reduced the risk of death by 40% in men with a type of advanced prostate cancer, marking an unprecedented 8-year overall survival rate of 78.9%.The European Union is exploring new legal avenues, including international maritime law on environmental or piracy grounds, to gain powers to board and potentially seize vessels belonging to Russia's "shadow fleet" in the Baltic Sea, escalating ...